↓ Skip to main content

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy

Overview of attention for article published in Frontiers in oncology, June 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
7 X users

Citations

dimensions_citation
275 Dimensions

Readers on

mendeley
597 Mendeley